Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Francesco Grossi,Piotr Jaśkiewicz,Marion Ferreira,Grzegorz Czyzewicz,Dariusz M. Kowalski,Libero Ciuffreda,Ramón García Gómez,Salvatore Caruso,Joaquim Bosch-Barrera,S. Gautier,Christine Ta Thanh Minh,Sebastien Henriet,Gilberto de Castro

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

2021

Francesco Grossi
Piotr Jaśkiewicz
Marion Ferreira
Grzegorz Czyzewicz
Dariusz M. Kowalski
Libero Ciuffreda
Ramón García Gómez
Salvatore Caruso
Joaquim Bosch-Barrera
S. Gautier
Christine Ta Thanh Minh
Sebastien Henriet
Gilberto de Castro

Objective:The study investigated the efficacy and safety of oral vinorelbine-cisplatin (OV-CDDP) and gemcitabine-cisplatin (GEM-CDDP) in patients with squamous non-small cell lung cancer (sq-NSCLC)...

Keywords:

Phases of clinical research
non small cell
Quality of life
Vinorelbine
Gemcitabine
Internal medicine
Oncology
first line therapy
in patient
Medicine
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations